-
STRENGTHENING DIAGNOSTIC VALIDITY IN COMMUNITY-RECRUITED DIGITAL REAL-WORLD STUDIES: A METHODOLOGICAL REVIEW
Aug 11, 2026, 17:16 PM -
ACCOUNTING FOR HIGH PLACEBO RESPONSE IN HEALTH TECHNOLOGY ASSESSMENT: EVIDENCE FROM NICE TECHNOLOGY APPRAISALS AND LESSONS FOR RCTS AND ECONOMIC MODELING FOR SJOGREN'S DISEASE
Aug 11, 2026, 17:16 PM -
THE RISE OF OUT-OF-POCKET PAYMENT FOR GLP-1 THERAPIES: IMPLICATIONS FOR TRADITIONAL PHARMACEUTICAL REIMBURSEMENT AND MARKET ACCESS IN EUROPE
Aug 11, 2026, 17:16 PM -
EVALUATION OF CASCADE GENETIC TESTING FOR BRCA1/2 MUTATION CARRIERS IN ITALY: A SEMI-MARKOV SIMULATION STUDY
Aug 11, 2026, 17:16 PM -
MULTI-COUNTRY SURGEONS-REPORTED REAL WORLD EXPERIENCE WITH A PREMIUM IOL
Aug 11, 2026, 17:16 PM -
COMMONALITIES IN DISEASE BURDEN AND UNMET NEED IN UNDERSERVED AUTOIMMUNE DISEASES
Aug 11, 2026, 17:16 PM -
ECONOMIC IMPACT OF BIMEKIZUMAB FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN FRANCE
Aug 11, 2026, 17:16 PM -
COMPARATIVE EFFICACY OF APPROVED IL-17 INHIBITORS FOR MODERATE-TO-SEVERE PLAQUE PSORIASIS: A SYSTEMATIC LITERATURE REVIEW & BAYESIAN NETWORK META-ANALYSIS
Aug 11, 2026, 17:16 PM -
HETEROGENEITY OF EVENT-FREE SURVIVAL DEFINITION IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Aug 11, 2026, 17:16 PM -
PLAYING THE WEIGHTING GAME: A TARGETED LITERATURE REVIEW OF REAL-WORLD EVIDENCE OF WEIGHT REGAIN AFTER GLP-1 RECEPTOR AGONIST DISCONTINUATION AND IMPLICATIONS FOR HEALTHCARE RESOURCE USE
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS MODELS OF LUNG CANCER SCREENING BY LDCT IN EUROPE FROM 2015 TO 2026: A SYSTEMATIC REVIEW AND METHODOLOGICAL ASSESSMENT ADAPTED FOR FRANCE
Aug 11, 2026, 17:16 PM -
PREFERENCES AND WILLINGNESS-TO-PAY FOR LYME DISEASE VACCINES IN THE UNITED STATES: A LATENT CLASS APPROACH
Aug 11, 2026, 17:16 PM -
PHENOTYPING TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AT POPULATION SCALE: VALIDATED LARGE LANGUAGE MODEL (LLM) EXTRACTION FROM US REAL-WORLD CLINICAL NOTES
Aug 11, 2026, 17:16 PM -
INTANGIBLE BURDENS AND THEIR RELENTLESS IMPACTS: BEYOND THE FINANCIAL COSTS OF LYSOSOMAL STORAGE DISORDERS (FABRY DISEASE, GAUCHER DISEASE TYPE 3, AND GM2 GANGLIOSIDOSES)
Aug 11, 2026, 17:16 PM -
A BAYESIAN LONGITUDINAL MULTILEVEL NETWORK META-REGRESSION MODEL FOR REPEATED CONTINUOUS OUTCOMES
Aug 11, 2026, 17:16 PM -
AI IN HEALTH ECONOMICS AND OUTCOMES RESEARCH SUFFERS FROM LOW EXPLAINABILITY, TRACEABILITY, REPRODUCIBILITY AND FROM HALLUCINATIONS: A TARGETED REVIEW OF CHALLENGES AND TECHNICAL MITIGATIONS
Aug 11, 2026, 17:16 PM -
THE "INVISIBLE" BURDEN: WORKPLACE DIFFICULTIES IN EARLY-STAGE RELAPSING-REMITTING MULTIPLE SCLEROSIS WITH LOW PHYSICAL DISABILITY
Aug 11, 2026, 17:16 PM -
ORIGINATOR PRICE REDUCTIONS AND UPTAKE-RELATED SAVINGS ASSOCIATED WITH BIOSIMILAR AVAILABILITY: A BUDGET IMPACT ANALYSIS OF 12 BIOLOGIC MOLECULES IN SOUTH KOREA
Aug 11, 2026, 17:16 PM -
ESTIMATING THE PREVALENCE OF TURNER SYNDROME IN THE UNITED STATES AND EUROPE: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
Aug 11, 2026, 17:16 PM -
AI-DRIVEN SYNTHETIC PATIENT GENERATION FRAMEWORK TO MODEL OBESITY USING THE CONSTANCES COHORT
Aug 11, 2026, 17:16 PM
